Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia

Minoryx Therapeutics completes enrollment in…

First patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia

Mataró, Barcelona, Spain and Charleroi,…